Stock ALXO ALX ONCOLOGY HOLDINGS INC.
Add to a list
To use this feature you must be a member
Log inSign up

News ALX Oncology Holdings Inc.

Equities

ALXO

US00166B1052

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-07-08 pm EDT 		5-day change 1st Jan Change
5.64 USD +3.49% Intraday chart for ALX Oncology Holdings Inc. -5.84% -62.12%
Jul. 01 ALX Oncology Holdings Inc.(NasdaqGS:ALXO) added to Russell Microcap Growth Index CI
Jul. 01 ALX Oncology Holdings Inc.(NasdaqGS:ALXO) dropped from Russell Microcap Value Index CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
ALX Oncology Holdings Inc.(NasdaqGS:ALXO) added to Russell Microcap Growth Index
CI
ALX Oncology Holdings Inc.(NasdaqGS:ALXO) dropped from Russell Microcap Value Index
CI
ALX Oncology Holdings Inc.(NasdaqGS:ALXO) dropped from Russell 3000E Value Index
CI
ALX Oncology Holdings Inc.(NasdaqGS:ALXO) dropped from Russell 3000 Value Index
CI
ALX Oncology Holdings Inc.(NasdaqGS:ALXO) dropped from Russell 2500 Value Index
CI
ALX Oncology Holdings Inc.(NasdaqGS:ALXO) dropped from Russell Small Cap Comp Value Index
CI
ALX Oncology Holdings Inc.(NasdaqGS:ALXO) added to Russell 3000E Growth Index
CI
ALX Oncology Holdings Inc.(NasdaqGS:ALXO) added to Russell 3000 Growth Index
CI
ALX Oncology Holdings Inc.(NasdaqGS:ALXO) dropped from Russell 2000 Value Index
CI
ALX Oncology Holdings Inc.(NasdaqGS:ALXO) added to Russell 2000 Growth Index
CI
ALX Oncology Holdings Inc.(NasdaqGS:ALXO) added to Russell 2500 Growth Index
CI
ALX Oncology Holdings Inc.(NasdaqGS:ALXO) added to Russell Small Cap Comp Growth Index
CI
ALX Oncology : Corporate Presentation
PU
ALX Oncology : ASPEN-07 Principal Investigator and ALX Oncology Management Presentation
PU
Transcript : ALX Oncology Holdings Inc. - Special Call
ALX Oncology Presents First Evorpacept Combination Data with an Antibody-Drug Conjugate from Phase 1 ASPEN-07 Clinical Trial in Patients with Advanced Bladder Cancer
AQ
ALX Oncology Holdings Inc. Presents First Evorpacept Combination Data with an Antibody-Drug Conjugate from Phase 1 Aspen-07 Clinical Trial in Patients with Advanced Bladder Cancer
CI
ALX Oncology Presents First Evorpacept Combination Data with an Antibody-Drug Conjugate from Phase 1 ASPEN-07 Clinical Trial in Patients with Advanced Bladder Cancer
GL
ALX Oncology Announces Participation in the Jefferies Global Healthcare Conference
GL
ALX Oncology Announces Participation in the Jefferies Global Healthcare Conference
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ALXO Stock
  4. News ALX Oncology Holdings Inc.